Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment

Bogoch, 2020, Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel, J. Travel Med., 27, 1, 10.1093/jtm/taaa008 Lu, 2020, Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle, J. Med. Virol., 92, 401, 10.1002/jmv.25678 Rothan, 2020, The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak, J. Autoimmun., 109, 102433, 10.1016/j.jaut.2020.102433 Li, 2020, Molecular immune pathogenesis and diagnosis of COVID-19, J. Pharm. Anal., 10, 102, 10.1016/j.jpha.2020.03.001 Lee, 2020, Gastrointestinal and liver manifestations in patients with COVID-19, J. Chin. Med. Assoc., 83, 1, 10.1097/JCMA.0000000000000319 Wu, 2020, Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern. Med., 1 Angeletti, 2020, COVID-2019: the role of the nsp2 and nsp3 in its pathogenesis, J. Med. Virol., 92, 584, 10.1002/jmv.25719 Maier, 2015, Coronaviruses: Methods and protocols, 1282, 10.1007/978-1-4939-2438-7 Masters, 2006, The molecular biology of coronaviruses, Adv. Virus Res., 65, 193, 10.1016/S0065-3527(06)66005-3 Knoops, 2008, SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum, PLoS Biol., 6, 1957, 10.1371/journal.pbio.0060226 Ge, 2013, Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor, Nature, 503, 535, 10.1038/nature12711 Raj, 2013, Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC, Nature, 495, 251, 10.1038/nature12005 Wrapp, 2020, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science (80-. )., 367, 1260, 10.1126/science.abb2507 Walls, 2017, Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion, Proc. Natl. Acad. Sci. U. S. A., 114, 11157, 10.1073/pnas.1708727114 Gui, 2017, Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding, Cell Res., 27, 119, 10.1038/cr.2016.152 Yuan, 2017, Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains, Nat. Commun. 8 Mille, 2014, Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein, Proc. Natl. Acad. Sci. U. S. A., 111, 15214, 10.1073/pnas.1407087111 Wang, 2008, SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway, Cell Res., 18, 290, 10.1038/cr.2008.15 Kuba, 2010, Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters, Pharmacol. Ther., 128, 119, 10.1016/j.pharmthera.2010.06.003 Song, 2019, 11, 59 Weiss, 2011, Chapter 4 - Coronavirus pathogenesis, 81, 85, 10.1016/B978-0-12-385885-6.00009-2 Perlman, 2009, Coronaviruses post-SARS: update on replication and pathogenesis, Nat. Rev. Microbiol., 7, 439, 10.1038/nrmicro2147 De Wit, 2016, SARS and MERS: recent insights into emerging coronaviruses, Nat. Rev. Microbiol., 14, 523, 10.1038/nrmicro.2016.81 Xu, 2020, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir. Med., 8, 420, 10.1016/S2213-2600(20)30076-X Fan, 2009, Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection, Arch. Virol., 154, 1093, 10.1007/s00705-009-0409-6 Tang, 2011, Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study, J. Immunol., 186, 7264, 10.4049/jimmunol.0903490 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Williams, 2014, The mercurial nature of neutrophils: Still an enigma in ARDS?, Am. J. Phys. Lung Cell. Mol. Phys., 306, L217 Snijder, 2006, Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex, J. Virol., 80, 5927, 10.1128/JVI.02501-05 Channappanavar, 2019, IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes, J. Clin. Invest., 129, 3625, 10.1172/JCI126363 Channappanavar, 2016, Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice, Cell Host Microbe, 19, 181, 10.1016/j.chom.2016.01.007 Niemeyer, 2013, Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist, J. Virol., 87, 12489, 10.1128/JVI.01845-13 Yang, 2013, The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists, Protein Cell, 4, 951, 10.1007/s13238-013-3096-8 Omrani, 2014, Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study, Lancet Infect. Dis., 14, 1090, 10.1016/S1473-3099(14)70920-X Saikatendu, 2005, Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1″-phosphate dephosphorylation by a conserved domain of nsP3, Structure, 13, 1665, 10.1016/j.str.2005.07.022 Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N. Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017 Chen, 2014, SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex, Protein Cell, 5, 369, 10.1007/s13238-014-0026-3 Subissi, 2014, One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities, Proc. Natl. Acad. Sci. U. S. A., 111, E3900, 10.1073/pnas.1323705111 Imbert, 2006, A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus, EMBO J., 25, 4933, 10.1038/sj.emboj.7601368 Chu, 2006, Antiviral activity of nucleoside analogues against SARS-coronavirus (SARS-CoV), Antivir. Chem. Chemother., 17, 285, 10.1177/095632020601700506 Shum, 2008, Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase, Chembiochem, 9, 3037, 10.1002/cbic.200800491 Jang, 2008, Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase, Biochem. Biophys. Res. Commun., 366, 738, 10.1016/j.bbrc.2007.12.020 Yu, 2012, Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13, Bioorg. Med. Chem. Lett., 22, 4049, 10.1016/j.bmcl.2012.04.081 Xia, 2014, Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein, Virus Res., 194, 200, 10.1016/j.virusres.2014.10.007 Millet, 2015, Host cell proteases: critical determinants of coronavirus tropism and pathogenesis, Virus Res., 202, 120, 10.1016/j.virusres.2014.11.021 Lan, 2020, Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor, Nature, 581, 215, 10.1038/s41586-020-2180-5 Narayanan, 2008, Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells, J. Virol., 82, 4471, 10.1128/JVI.02472-07 Taylor, 2015, Severe acute respiratory syndrome coronavirus ORF7a inhibits bone marrow stromal antigen 2 Virion tethering through a novel mechanism of glycosylation interference, J. Virol., 89, 11820, 10.1128/JVI.02274-15 Holshue, 2020, First case of 2019 novel coronavirus in the United States, N. Engl. J. Med., 382, 929, 10.1056/NEJMoa2001191 Wang, 2020, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res., 30, 269, 10.1038/s41422-020-0282-0 Warren, 2016, Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys, Nature, 531, 381, 10.1038/nature17180 Zhang, 2020, Binding mechanism of remdesivir to SARS-CoV-2 RNA dependent RNA polymerase, J. Phys. Chem. B 124, 82, 6955, 10.1021/acs.jpcb.0c04198 Cao, 2020, Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence, Travel Med. Infect. Dis., 35, 101647, 10.1016/j.tmaid.2020.101647 Grein, 2020, Compassionate use of Remdesivir for patients with severe Covid-19, N. Engl. J. Med., 382, 2327, 10.1056/NEJMoa2007016 Choy, 2020, Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro, Antivir. Res., 178, 104786, 10.1016/j.antiviral.2020.104786 Shereen, 2020, COVID-19 infection: origin, transmission, and characteristics of human coronaviruses, J. Adv. Res., 24, 91, 10.1016/j.jare.2020.03.005 Wang, 2020, Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China, J. Med. Virol., 92, 441, 10.1002/jmv.25689 Devaux, 2020, New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?, Int. J. Antimicrob. Agents, 55, 105938, 10.1016/j.ijantimicag.2020.105938 Tu, 2020 Colson, 2020, Chloroquine and hydroxychloroquin+e as available weapons to fight COVID-19, Int. J. Antimicrob. Agents, 55, 105932, 10.1016/j.ijantimicag.2020.105932 Nichol, 2020, Potential implications of testing an experimental mRNA-based vaccine during an emerging infectious disease pandemic, Am. J. Bioeth., 20, W2, 10.1080/15265161.2020.1763696